Colchicine in Patients with Chronic Coronary Disease

Abstract

In a randomized trial involving patients with chronic coronary disease, the risk of cardiovascular events was significantly lower among those who received 0.5 mg of colchicine once daily than among those who received placebo. (Funded by the National Health Medical Research Council of Australia and others; LoDoCo2 Australian New Zealand Clinical Trials Registry number, ACTRN12614000093684.).

Keywords

ColchicineMedicineMyocardial infarctionInternal medicineCardiologyCoronary heart diseaseDiseaseCoronary disease

Affiliated Institutions

Related Publications

Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

R B Sleight , Peter Sleight , Sarah Parish +3 more

17,187 patients entering 417 hospitals up to 24 hours (median 5 hours) after the onset of suspected acute myocardial infarction were randomised, with placebo control, between: (...

1988 PubMed 2873 citations

Dexamethasone in Hospitalized Patients with Covid-19.

Peter Horby , Wei Shen Lim , Jonathan Emberson +23 more

BACKGROUND: Coronavirus disease 2019 (Covid-19) is associated with diffuse lung damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce progres...

2020 DiRROS repository (University of Mari... 8025 citations

Publication Info

Year: 2020
Type: article
Volume: 383
Issue: 19
Pages: 1838-1847
Citations: 1837
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Colchicine in Patients with Chronic Coronary Disease

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1837

OpenAlex

Cite This

APA Style

                            
                                
                                    Stefan M. Nidorf, 
                                
                                    Aernoud T.L. Fiolet, 
                                
                                    Arend Mosterd
                                
                                et al.
                            
                            (2020). 
                            Colchicine in Patients with Chronic Coronary Disease. 
                            New England Journal of Medicine
                            , 383
                            (19)
                            , 1838-1847.
                            https://doi.org/10.1056/nejmoa2021372
                        

Identifiers

DOI: 10.1056/nejmoa2021372